greeksoup/ stock research

Marsh & McLennan Companies, Inc.: Q3 FY2026 earnings call

What management said about Q3 FY2026, from the documents filed with the SEC on 15 October 2026: press release. The quarter’s numbers.

Key takeaways

  • Revenue up 8%, underlying up 5%: Consolidated revenue was $6,863 million, up 8% from $6,351 million. Underlying growth of 5% excluded an acquisition and other impact of 3 points. Currency added no points. Source
  • Adjusted EPS up 10% to $2.03: Diluted EPS was $1.69, against $1.51 a year earlier. Adjusted EPS was $2.03, against $1.85, according to the reconciliation schedule. Source
  • Risk revenue up 10%, underlying 5%: Risk revenue was $3,726 million, up 10% from $3,400 million. U.S./Canada underlying growth was 4% and International underlying growth was 6%. Source
  • Management Consulting up 14%: Management Consulting revenue was $1,013 million, up 14% on both reported and underlying bases. Nine-month underlying revenue growth was 11%. Source
  • Thrive restructuring costs increased: Restructuring charges were $79 million, against $46 million. Nine-month restructuring charges were $182 million, against $96 million, and mainly relate to the Thrive program. Source
  • Buybacks of $500 million in quarter: The company repurchased about 2.7 million shares for $500 million in the quarter. Shares outstanding at September 30 were 475 million, against 490 million a year earlier. Source
  • Deasterra gain sits in revenue: A $126 million gain from remeasuring the previously held Deasterra Partners stake is in Q3 revenue. It is excluded from underlying revenue and from adjusted operating margin. Source

“We also made significant progress in executing our Thrive program and successfully completed our brand transition.”

John Doyle, President and CEO

What changed from last quarter

  • New: Segment names changed. Guy Carpenter results are now reported as Reinsurance and Mercer results as People and Investments. Wealth, Health and Career became Investments and Retirement, Health and Benefits and Workforce and Rewards. Source

Results and earnings

  • Revenue up 8%, underlying up 5%: Consolidated revenue was $6,863 million, up 8% from $6,351 million. Underlying growth of 5% excluded an acquisition and other impact of 3 points. Currency added no points. Source
  • Adjusted EPS up 10% to $2.03: Diluted EPS was $1.69, against $1.51 a year earlier. Adjusted EPS was $2.03, against $1.85, according to the reconciliation schedule. Source
  • Operating income and adjusted operating income rose: GAAP operating income rose 4% to $1,215 million. Adjusted operating income rose 6% to $1,527 million, from $1,439 million, after excluding noteworthy items and identified intangible amortization. Source
  • Nine-month EPS down, adjusted EPS up: Nine-month diluted EPS was $6.68, against $6.75. Nine-month adjusted EPS rose 9% to $8.29. Nine-month GAAP operating income fell 3% to $4,868 million. Source

Risk and Reinsurance

  • Risk revenue up 10%, underlying 5%: Risk revenue was $3,726 million, up 10% from $3,400 million. U.S./Canada underlying growth was 4% and International underlying growth was 6%. Source
  • International growth by region: EMEA underlying revenue grew 7% and Asia Pacific grew 4%. Latin America was flat on an underlying basis, though it grew 7% on a reported basis. Source
  • Reinsurance revenue fell 6%: Reinsurance revenue was $374 million, against $398 million, down 6% on both GAAP and underlying bases. Nine-month Reinsurance underlying revenue decreased 1%. Source

“These results reflect the strength of our market position, the value we deliver to clients, and the commitment of our colleagues around the world.”

John Doyle, President and CEO

Consulting and People and Investments

  • Consulting revenue up 9%: Consulting revenue was $2,685 million, up 9% reported and 8% underlying. Operating income rose 12% to $563 million and adjusted operating income rose 9% to $593 million. Source
  • Management Consulting up 14%: Management Consulting revenue was $1,013 million, up 14% on both reported and underlying bases. Nine-month underlying revenue growth was 11%. Source
  • Mixed results across People and Investments: People and Investments revenue was $1,672 million, up 5% underlying. Investments and Retirement and Health and Benefits grew, while Workforce and Rewards declined 1%. Source

Costs and margins

  • Compensation and other costs rose: Compensation and benefits were $4,078 million, against $3,894 million. Other operating expenses were $1,570 million, against $1,287 million. Source
  • Adjusted margin flat at 22.7%: Consolidated adjusted operating margin was 22.7% in both the third quarters of 2026 and 2025. Risk and Insurance Services was 24.6%, against 24.7%, and Consulting was 22.1% in both years. Source
  • Thrive restructuring costs increased: Restructuring charges were $79 million, against $46 million. Nine-month restructuring charges were $182 million, against $96 million, and mainly relate to the Thrive program. Source

Cash, debt and share repurchases

  • Buybacks of $500 million in quarter: The company repurchased about 2.7 million shares for $500 million in the quarter. Shares outstanding at September 30 were 475 million, against 490 million a year earlier. Source
  • Nine-month buybacks reached $2.0 billion: Nine-month repurchases totalled 11.4 million shares for $2.0 billion, against $1,002 million of treasury share purchases in the prior-year period. Source
  • Euro notes repaid at maturity: The company repaid 550 million of Euro-denominated senior notes that matured in September. Nine-month debt repayments totalled $1,247 million. Source
  • Operating cash flow lower, dividends higher: Nine-month net cash from operations was $2,313 million, against $3,131 million. Dividends paid were $1,354 million, against $1,255 million. Source

Strategy, brand and Thrive

  • Brand renamed to Marsh: From January 14, 2026, the company's brand became Marsh. Oliver Wyman Group businesses became Marsh Management Consulting, and Marsh businesses became Marsh Risk. Source
  • Thrive covers brand, clients, growth and efficiency: Thrive is a three-year program. It focuses on brand strategy, delivering greater value to clients, accelerating growth and improving efficiency, and its costs are reported as restructuring. Source
  • Thrive expected to generate savings: Management said Thrive will generate savings from process and automation efficiencies and from optimizing the global operating model. Source

Noteworthy items and legal matters

  • Deasterra gain sits in revenue: A $126 million gain from remeasuring the previously held Deasterra Partners stake is in Q3 revenue. It is excluded from underlying revenue and from adjusted operating margin. Source
  • Restrictive covenant legal costs: Legal costs of $30 million in the quarter relate to restrictive covenant litigation against a competitor. Nine-month costs were $38 million. Source
  • Noteworthy items total rose: Total noteworthy items were $170 million, against $136 million. Identified intangible amortization was $142 million, against $133 million. Source

Figures management reported

FigureReported
Investment income Source$8 million in Q3 2026; $15 million in Q3 2025

Risks management discussed

  • Regulatory: Greensill litigation settlement and legal expenses, net of insurance recoveries, were $144 million in the quarter and $569 million for nine months. Source
  • Operational: McGriff integration and retention related costs were $35 million in the quarter and $124 million for nine months. Source

Earlier plans management reported on

  • Met: The CEO says the brand transition was successfully completed in the quarter. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.